Amedisys Inc (STU:ADY)
€ 87 0.5 (0.58%) Market Cap: 2.89 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.86 GF Score: 85/100

Amedisys Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2020 / 07:00PM GMT
Release Date Price: €212 (-4.50%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Hi, everyone. I'm A.J. Rice, the health care services analyst at Crédit Suisse. Thanks for dialing in for another presentation. We're very pleased to have next up, Amedisys, leading home health provider. From the management team, we have Paul Kusserow, President and CEO; Chris Gerard, Chief Operating Officer; Scott Ginn, Chief Financial Officer; and Nick Muscato, Chief of Staff and VP of Strategic Finance.

Amedisys just posted a strong quarter last week. And I thought maybe first off, and just to set the stage for people, especially if you're new to the story, I might ask Paul or the team to just take -- give us some insights into the 1, 2, 3 takeaways from the quarter as you look out for the rest of the year and into next year.

Paul Berthold Kusserow
Amedisys, Inc. - Chairman, President & CEO

Great. Thanks, A.J. Yes, we were very pleased with how the quarter ended up. We're pleased with how the year is looking, and we feel extraordinarily

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot